Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 8, Issue 1, Pages 27-33
http://dx.doi.org/10.1155/2001/508015
Original Article

Economic Impact of Using an Immunostimulating Agent to Prevent Severe Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease

Jean-Paul Collet,1,2 Thierry Ducruet,1 Seema Haider,3 Stan Shapiro,1,2 Ann Robinson,1 Paolo M Renzi,4,5 André-Pierre Contandriopoulos,5,6 and Pierre Ernst2,3

1Centre for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, Montréal, Québec, Canada
2Department of Epidemiology and Biostatistics, McGill University, Montréal, Québec, Canada
3Respiratory Division, McGill University Health Centre, Montréal, Québec, Canada
4Centre Hospitalo-Universitaire de Montréal, Pavillon Notre Dame, Département de Pneumologie, Montréal, Québec, Canada
5Université de Montréal, Montréal, Québec, Canada
6Groupe de Recherche Interdisciplinaire en Santé, Université de Montréal, Montréal, Québec, Canada

Copyright © 2001 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jean-Paul Collet, Thierry Ducruet, Seema Haider, et al., “Economic Impact of Using an Immunostimulating Agent to Prevent Severe Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease,” Canadian Respiratory Journal, vol. 8, no. 1, pp. 27-33, 2001. https://doi.org/10.1155/2001/508015.